Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
As with other medicines in the incretin-based drug class, retatrutide is associated with a range of side effects, the majority of which relate to the gastrointestinal system
Cardiovascular outcome trials (including LEADER, SUSTAIN-6, REWIND, and SELECT) have demonstrated that certain GLP-1 receptor agonists reduce major adverse cardiovascular events in patients with established cardiovascular disease or multiple risk factors
Just science-backed results
Available formats for Retatrutide Canada: For a general overview of available formats and batch transparency, see our Retatrutide Canada research overview
US$ 28.86
US$ 26.37
US$ 20.26
US$ 29.90
US$ 25.25
US$ 20.52
US$ 24.02
